Patients from Nepal: the border route, the referral chain and repeat travel
Patients from Nepal usually arrive overland, referred by a named doctor rather than by a campaign, and they return repeatedly for cycles, dialysis and follow-up. Most hospitals register them as ordinary walk-ins, so the market never appears in reporting. Record country at registration, fix internal routing, send reports back to referring doctors, and build a returning-patient pathway.
Ask a hospital in Gorakhpur, Siliguri or Patna how many international patients it treats and you will often be told: very few. Ask the same hospital how many patients come from across the northern border and the answer changes completely. The patients are there. They are simply coded as ordinary outpatients, because they walked in like ordinary outpatients.
That coding decision is the whole problem. It hides patients from Nepal from reporting, keeps the international desk out of the conversation, and leaves nobody responsible for the parts of the journey that are genuinely different: the referring doctor on the other side, the document the patient needs for reimbursement at home, the medicines that must last until the next visit.
This article is about that market as an operating problem. Not the brochure version, where medical value travel means a suite room and an airport pickup, but the version that actually happens: a bus, a border post, a crowded morning clinic and a family that will be back in three weeks.
Why patients from Nepal are the market your reporting hides
Almost everything that makes other international markets visible is absent here. There is usually no facilitator sending a case file ahead. There is often no invitation letter, because entry arrangements between the two countries are not the same as those for other source markets, and the family may simply arrive. There is frequently no advance enquiry at all, because somebody in the family travelled last year and already knows the way.
So the case never touches the international desk, never gets a country tag, and never appears in the pack that goes to the board. The hospital then concludes that the market is small and stops investing, which is a conclusion drawn from a data entry habit rather than from demand.
The fix is unglamorous and works immediately. Add a country field at registration, make it mandatory, and train the front office to ask rather than assume. Within one quarter you will have a real picture, and it will usually be larger than the one in anyone’s head. Then you can make decisions about it. I have argued the general case for this in the piece on reading international demand from data, and this is the market where the argument pays off fastest.
The route decides who you compete with
Road, and the towns that feed it
Most families travel by road. The crossings in the west feed into eastern Uttar Pradesh, the central crossings feed into Bihar, and the eastern crossings feed into north Bengal. A family then continues by bus, shared vehicle or train to whichever Indian city their doctor or their relative named. Road transfers by ambulance happen too, including cases that leave a hospital on the other side and arrive at your gate with no warning and no notes.
The distances involved are not trivial once the border is behind them. A family that crossed at dawn may still have most of a day of travel ahead before they reach the city their doctor named, and they will have arranged nothing at the other end. Your front office is dealing with people at the end of a long journey who have not eaten, have not slept and are holding a folder of reports in a plastic bag.
Road travel means arrivals cluster early in the morning, after an overnight journey, with a patient who has been sitting upright for hours. It also means the family can go home and come back cheaply, so they will not accept a plan that requires them to stay if staying is avoidable.
Air, and the different case it carries
Flights from Kathmandu reach Delhi, Lucknow, Varanasi, Kolkata and the southern metros. The family that flies is usually travelling for something the border cities cannot do: a transplant, complex cardiac or neurosurgery, advanced oncology, a paediatric case that needs a named subspecialty. The enquiry arrives in advance, often through a doctor rather than a website, and the family expects to be met.
These are two different businesses. A border-city unit competes with other border-city units on access, cost of the journey and how quickly a patient is seen. A metro unit competes with other metros on the named clinician and the specific capability. Groups that run both keep losing cases at the seam, because the border unit hangs on to a case it cannot finish and the metro unit has no reason to send routine follow-up back. Fix the internal routing rule before you spend anything on demand.
The referral chain is human, and it does not live online
In most source markets you build awareness and wait for an enquiry. Here the case usually reaches you because a person sent it. A consultant in Kathmandu or in a terai town who trained in India and still trusts a particular department. A diagnostic centre that reads a scan and says this needs a bigger centre. A pharmacist. A relative who travelled last year. The route is a chain of individuals, and it is remarkably durable.
This has three consequences for how you work. First, the referring doctor is your customer and you are almost certainly not serving them. They want the report back, promptly, in a form they can act on, and they want to be told what happened to the patient they sent. Most Indian hospitals send nothing. The general approach is set out in the piece on building an international doctor referral network, and the discipline it describes matters more here than the marketing does.
Second, an intermediary layer exists in this market, made up of individuals who arrange travel and accompany families. Your only defensible position is a published, written commercial policy that applies to everyone and does not change case by case. Decide what you will and will not do, put it in writing, and let the desk say no consistently.
There is also a quiet advantage in this structure that most teams miss. A referral chain made of individuals is cheap to serve and almost impossible for a competitor to buy. No campaign outspends a consultant who has watched your department handle their patients well for years. The investment that protects it is not media money at all: it is turnaround time on reports, a phone that gets answered, and a consultant of yours who will take a call from a doctor they have never met.
Third, the chain is slow to build and fast to break. One patient sent back with an unreadable discharge summary and a bill nobody explained will close a referral route that took years to open, and you will never be told why the cases stopped.
Language sounds solved and the paperwork is not
Conversation usually works. Hindi is widely understood along the travel routes, staff manage, the consultation flows, and everyone leaves feeling understood. That fluency is exactly what makes the written side dangerous, because nobody notices a comprehension gap when the talking went well.
The gap shows up later. A discharge summary written for an Indian general practitioner, in English, with Indian brand names for medicines, is close to useless to a doctor on the other side of the border who has different products available. A diet instruction written around ingredients the family does not buy will simply be ignored. A consent explanation given verbally in a mixed vocabulary is not the same as a consent the family can read.
Two practical rules cover most of it. Write discharge instructions with the molecule named, not only the product, so the medicine can be dispensed at home. And ask the family, before discharge, who will look after the patient when they get back and whether that person can read what you have written. If the answer is unclear, the plan is not finished.
Money is easy to exchange and hard to receipt
Currency is less of an obstacle here than in most source markets. Exchange is routine, the border economy handles it daily, and families arrive with a workable mix of cash and cards. The friction is on the other side of the transaction.
Families need documents that work at home: a bill in a format an employer or a scheme will accept, a receipt naming the patient exactly as their own identity document names them, a certificate stating the treatment in language a non-clinical administrator can process. When those documents are wrong, the family comes back to your billing counter weeks later, from another country, to get them reissued. That is a bad experience and a real cost to you.
So treat documentation as a deliverable of the episode, not as an afterthought. Ask at registration whether anyone will be claiming reimbursement at home and what that body needs. Get the name spelling right at the first counter, from the travel document, and use the same spelling everywhere. Cash handling deserves a written policy too, with a named owner, because a busy border-city unit will otherwise improvise one.
The visit that comes back, again and again
The defining feature of this market is repetition. Chemotherapy cycles. Dialysis during a stay. Transplant follow-up that continues for years. Cardiac and paediatric reviews. A family may make the same journey many times, and each journey costs them days and money that have nothing to do with your bill.
Almost no hospital designs for the returning patient, and the opportunity is large. A returning-patient pathway is not complicated. Book the next visit before the family leaves. Hold the slot. Give them a written medicine plan that lasts until that date, with the molecule named. Tell them who to message if something changes, and answer. Where a review can be done remotely, offer it, and say so before they travel, which is the argument in the piece on teleconsultation before travel and follow-up afterwards.
Measure this as its own number. Not conversion, not enquiries: the share of patients from this market who return for the review you planned. In my experience, that one figure predicts the health of the whole market better than anything the marketing team reports.
What not to copy from other markets
Plenty of standard international desk practice makes no sense here, and importing it wastes money. Airport protocol is irrelevant to a family arriving by bus. Package pricing designed to be quoted in a foreign currency adds a layer nobody asked for. A lounge, a dedicated floor and a concierge are built for a market where the patient expects to be hosted, and this is a market where the patient expects to be seen quickly and allowed to go home.
The contrast with a market like medical travel from Bangladesh is instructive, because the two are often lumped together as neighbouring demand. They are not the same. One arrives in large family groups and compares hospitals in person. This one arrives through a named doctor and comes back on a schedule. The service design that wins each is different.
Where to begin, and what to leave alone
Begin with the country field at registration. Until you know how many, from where, and for what, every other decision is guesswork dressed as strategy.
Second, write the internal routing rule between your border-city units and your metro units, and make the border unit whole for a case it hands over. Without that, your own network competes with itself and the family absorbs the confusion.
Third, send the referring doctor a report. Pick the consultants who send you the most cases, and set a standing rule that a summary goes back within a fixed number of days of discharge. This is the cheapest referral marketing available and almost nobody does it.
Fourth, build the returning-patient pathway: booked next visit, held slot, medicine plan by molecule, one contact who replies. Measure the return rate.
What to leave alone: the hospitality layer, the brochure translated into a language most of your visitors read only partly, and any attempt to build an exclusive relationship with intermediaries. Spend the money on early morning clinic capacity, on documents that work at home, and on answering messages. Families in this market are not choosing between countries. They are choosing between the hospital that remembered them and the one that did not.
Questions people ask
The journey is mostly overland, the referral usually comes from a named doctor rather than a website, and the same family often returns many times for cycles, dialysis or follow-up. Entry arrangements differ from those for other source markets, so families can arrive without an advance enquiry and without a case file. The result is a market that is large in practice and invisible in most hospital reporting.
Because these patients walk in and get registered like local outpatients, with no country recorded. There is often no facilitator, no invitation letter and no advance email, so nothing routes the case to the international desk. The hospital then reports a small international number and concludes the market is unimportant. Adding a mandatory country field at registration usually reveals a much larger picture within a single quarter.
The unit owns the clinical episode and the front office experience, and the desk owns the things that are genuinely cross-border: documentation for use at home, the referring doctor relationship, language cover for written material, and reporting. Trying to route every walk-in through a central desk will fail because the volume is too high and the arrivals are unplanned. Shared ownership with clear boundaries works better.
A report they can act on, sent promptly, and news of what happened to the patient they trusted you with. Most Indian hospitals send nothing back, which is why referral routes quietly close. Set a standing rule that a summary goes to the referring doctor within a fixed period after discharge, name the molecule rather than only the product, and give that doctor a direct way to ask a question.
With a written commercial policy that applies to everybody and does not change case by case. Decide what your hospital will and will not do, publish it internally, and let the desk decline consistently without negotiating at the counter. Inconsistency is what creates pressure, disputes and reputational risk. A clear, boring, unchanging policy is easier to defend than a series of individual judgements.
Spoken communication usually works, which is exactly why the written gap goes unnoticed. Discharge summaries in English, with Indian product names, are hard for a doctor across the border to act on, and diet advice built around unfamiliar ingredients gets ignored. Name molecules, keep instructions plain, and check before discharge that whoever will care for the patient at home can read what you have written.
Exchange itself is rarely the obstacle. The costs sit in cash handling at busy units and in documentation that has to be reissued later because a name was spelled differently or a certificate did not match what a scheme at home requires. Ask at registration whether anyone will claim reimbursement, capture the name from the travel document once, and put a named owner on cash policy.
Track arrivals by country, split walk-in from referred, and then measure the share of patients who return for the review you planned. Return rate is a better health check than conversion, because the market is built on repetition rather than on one-time cases. Add a simple measure of how quickly reports reach referring doctors, since that predicts the next quarter’s referrals.
Less than you would expect. Demand mostly moves through people: a consultant, a diagnostic centre, a relative who travelled before. Content still helps families check that you are real and find directions, timings and departments, but paid campaigns aimed at a market that already knows the route mostly buy clicks from people who were coming anyway. Spend on clinic capacity, documentation and reply speed first.
Border units win on access: early clinic hours, short waits, same-day investigations and a clear answer the family can travel home with. Metro units win on named capability for complex cases. The group rule that matters is internal routing, with the border unit made whole when it hands a case over. Without that rule, units compete with each other and families experience the confusion.
Registration data changes within weeks, referral reporting within a quarter, and return visits over a longer horizon because they follow clinical cycles rather than campaigns. Judge the first period on process: country capture, report turnaround to referring doctors, and whether the next visit was booked before discharge. Arrival growth follows, but it will lag, and pushing for it too early usually produces discounting instead of demand.
They happen, and they are where process gets tested. Agree in advance who accepts the handover, what happens when no notes arrive with the patient, how identity is recorded when documents are incomplete, and who authorises treatment before payment is settled. Write it down and brief the night shift. The alternative is that each such arrival is improvised by whoever is on duty, with predictable results.
Make country a mandatory field at registration across every unit near the border, and brief the front office to ask rather than guess. It takes a morning to set up and it converts an invisible market into a manageable one. Everything else, from routing rules to referring doctor reports, depends on knowing who is actually walking through the door.
